The Role of Vitamin B in Stroke Prevention A Journey From Observational Studies to Clinical Trials and Critique of the VITAmins TO Prevent Stroke (VITATOPS)

被引：21

作者：

Saposnik, Gustavo ^{[1
,2
,3
,4
,5
]}

机构：

[1] Univ Toronto, St Michaels Hosp, Stroke Outcomes Res Unit,Dept Med, Stroke Outcomes Res Canada SORCan,Div Neurol, Toronto, ON M5C 1R6, Canada

[2] Inst Clin Evaluat Sci, Toronto, ON, Canada

[3] Li Ka Shing Knowledge Inst, Toronto, ON, Canada

[4] Univ Toronto, Dept Med, Toronto, ON M5C 1R6, Canada

[5] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5C 1R6, Canada

来源：

STROKE | 2011年 / 42卷 / 03期

关键词：

folic acid; homocysteinemia; meta-analysis; prevention; stroke management; Vitamin B complex; RANDOMIZED CONTROLLED-TRIAL; FOLIC-ACID SUPPLEMENTATION; TRANSIENT ISCHEMIC ATTACK; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; LOWERING HOMOCYSTEINE; DIABETIC-NEPHROPATHY; EFFICACY ANALYSIS; VASCULAR-DISEASE; HEART-DISEASE;

D O I：

10.1161/STROKEAHA.110.608356

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：838 / 842

页数：5

共 50 条

[31] Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies
Liu, Xin
Xu, Zi-Xuan
Yu, Peng
Yuan, Ping
Zhu, Wen-Gen
CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (04) : 569 - 578
[32] Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies
Xin Liu
Zi-Xuan Xu
Peng Yu
Ping Yuan
Wen-Gen Zhu
Cardiovascular Drugs and Therapy, 2020, 34 : 569 - 578
[33] Endpoint data from secondary stroke prevention clinical trials is modified by patient preference for various health outcome states
Selco, SL
Saver, J
NEUROLOGY, 2004, 62 (07) : A467 - A467
[34] Gaps in translation from trials to practice: Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation
Hylek, Elaine M.
Ko, Darae
Cove, Christina L.
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 783 - 788
[35] Reconciling the Divergent Findings from Clinical Trials and Observational Studies of Menopausal Hormone Therapy for Prevention of Coronary Heart Disease
Rossouw, Jacques E.
SEMINARS IN REPRODUCTIVE MEDICINE, 2014, 32 (06) : 426 - 432
[36] A Variant in the Adenosine 2B Receptor Gene is Associated With Homocysteine Levels and Stroke Severity in African American Subjects From the Vitamin Intervention for Stroke Prevention (VISP) Trial
Sale, Michele M.
Hsu, Fang-Chi
Mychaleckyj, Josyf C.
Rich, Stephen S.
Furie, Karen L.
Worrall, Bradford B.
STROKE, 2010, 41 (04) : E334 - E334
[37] From efficiency in trials to effectiveness in clinical practice.: The Swedish stroke prevention study (SSPS):: A population-based, controlled study of blood pressure intervention and stroke incidence
Persson, M.
Carlberg, B.
Dahlstrom, J.
Lonnberg, G.
Nilsson, S.
Norberg, M.
Nystrom, L.
Weinehall, L.
Lindholm, L. H.
JOURNAL OF HYPERTENSION, 2008, 26 : S295 - S295
[38] Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials
Hart, Robert G.
Katsanos, Aristeidis H.
Perera, Kanjana S.
Eikelboom, John W.
CANADIAN JOURNAL OF CARDIOLOGY, 2023, 39 (02) : 187 - 197
[39] Topic: AS19 Clinical Trials (observational and randomized studies) ISCHEMIC STROKE SUBTYPES: A COMPARISON BETWEEN CAUSATIVE AND PHENOTYPIC CLASSIFICATIONS IN A TERTIARY HOSPITAL IN THE PHILIPPINES
Inting, K.
Canete, M. T.
INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 28 - 28
[40] Topic: AS19 Clinical Trials (observational and randomized studies) EFFECTOF DIABETES MELLITUS ON REMOTE ISCHEMIC POST-CONDITIONING IN PATIENTS WITH ACUTE ISCHEMIC STROKE
Vekhande, C.
Brar, S.
George, U.
Buck, B.
Butcher, K.
Shuaib, A.
Hess, D.
Kate, M.
INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (2_SUPPL) : 69 - 69

← 1 2 3 4 5 →